| abstract |
The present invention provides biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds of the following formula I, isomers thereof, or pharmaceutically acceptable salts. The compounds of the invention show a CETP inhibitory effect that increases HDL-cholesterol levels and reduces LDL-cholesterol levels. Pharmaceutical compositions comprising the compounds are useful for the prevention or treatment of dyslipidemia or dyslipidemia-related diseases. (see Formula I) |